F. C. Kischkel, S. Hellbardt, and I. Behrmann, Cytotoxicitydependent APO-1 (Fas/CD95)-associated proteins form a deathinducing signaling complex (DISC) with the receptor, EMBO J, vol.14, pp.5579-5588, 1995.

P. H. Krammer, CD95's deadly mission in the immune system, Nature, vol.407, pp.789-795, 2000.

M. Ehrenschwender and H. Wajant, The role of FasL and Fas in health and disease, Adv Exp Med Biol, vol.647, pp.64-93, 2009.

M. E. Peter, R. C. Budd, and J. Desbarats, The CD95 receptor: apoptosis revisited, Cell, vol.129, pp.447-450, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00318978

T. Sato, S. Irie, S. Kitada, and J. C. Reed, FAP-1: a protein tyrosine phosphatase that associates with Fas, Science, vol.268, pp.411-415, 1995.

I. Daigle, S. Yousefi, M. Colonna, D. R. Green, and H. U. Simon, Death receptors bind SHP-1 and block cytokine-induced antiapoptotic signaling in neutrophils, Nat Med, vol.8, pp.61-67, 2002.

M. Irmler, M. Thome, and M. Hahne, Inhibition of death receptor signals by cellular FLIP, Nature, vol.388, pp.190-195, 1997.

A. Vassilev, Z. Ozer, C. Navara, S. Mahajan, and F. M. Uckun, Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 deathinducing signaling complex, J Biol Chem, vol.274, pp.1646-1656, 1999.

G. López-herrera, A. Vargas-hernández, and G. Me, Bruton's tyrosine kinase-an integral protein of B cell development that also has an essential role in the innate immune system, J Leukoc Biol, vol.95, pp.243-250, 2014.

A. J. Mohamed, L. Yu, and C. M. Bäckesjö, Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain, Immunol Rev, vol.228, pp.58-73, 2009.

K. Saito, K. F. Tolias, and A. Saci, BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity, Immunity, vol.19, pp.669-678, 2003.

C. I. Smith, From identification of the BTK kinase to effective management of leukemia, Oncogene, vol.36, p.2045, 2016.

E. Grassilli, F. Pisano, and A. Cialdella, A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation, Oncogene, vol.35, pp.4368-4378, 2016.

W. Guo, R. Liu, and G. Bhardwaj, Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor, Cell Death Dis, vol.5, p.1409, 2014.

X. Wang, J. Wong, and C. J. Sevinsky, Bruton's tyrosine kinase inhibitors prevent therapeutic escape in breast cancer cells, Mol Cancer Ther, vol.15, pp.2198-2208, 2016.

S. Middendorp, G. M. Dingjan, A. Maas, K. Dahlenborg, and R. W. Hendriks, Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity, J Immunol, vol.171, pp.5988-5996, 2003.

J. R. Tumang, R. S. Negm, and L. A. Solt, BCR engagement induces Fas resistance in primary B cells in the absence of functional Bruton's tyrosine kinase, J Immunol, vol.168, pp.2712-2719, 2002.

A. Khare, B. Viswanathan, and R. Gund, Role of Bruton's tyrosine kinase in macrophage apoptosis, Apoptosis, vol.16, pp.334-346, 2011.

U. Schmidt, E. Van-den-akker, and M. Parren-van-amelsvoort, Btk is required for an efficient response to erythropoietin and for SCF-controlled protection against TRAIL in erythroid progenitors, J Exp Med, vol.199, pp.785-795, 2004.

H. P. Mcnamee, D. E. Ingber, and M. A. Schwartz, Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGFinduced inositol lipid breakdown, J Cell Biol, vol.121, pp.673-678, 1993.

A. Honda, M. Nogami, and T. Yokozeki, Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation, Cell, vol.99, pp.521-532, 1999.

D. Paolo, G. , D. Camilli, and P. , Phosphoinositides in cell regulation and membrane dynamics, Nature, vol.443, pp.651-657, 2006.

K. H. Lee, C. Feig, and V. Tchikov, The role of receptor internalization in CD95 signaling, EMBO J, vol.25, pp.1009-1023, 2006.

K. Chakrabandhu and A. O. Hueber, Fas versatile signaling and beyond: pivotal role of tyrosine phosphorylation in contextdependent signaling and diseases, Front Immunol, vol.7, p.429, 2016.

K. Kwiatkowska, One lipid, multiple functions: how various pools of PI(4,5)P(2) are created in the plasma membrane, Cell Mol Life Sci, vol.67, pp.3927-3946, 2010.

K. Chakrabandhu, Z. Hérincs, and S. Huault, Palmitoylation is required for efficient Fas cell death signaling, EMBO J, vol.26, pp.209-220, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00165458

S. Fais, D. Milito, A. Lozupone, and F. , The role of FAS to ezrin association in FAS-mediated apoptosis, Apoptosis, vol.10, pp.941-947, 2005.

E. Iessi, L. Zischler, and A. Etringer, Death receptor-induced apoptosis signalling regulation by ezrin is cell type dependent and occurs in a disc-independent manner in colon cancer cells, PLoS ONE, vol.10, p.126526, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01158055

L. Zhu, B. Derijard, K. Chakrabandhu, B. S. Wang, H. Z. Chen et al., Synergism of PI3K/Akt inhibition and Fas activation on colon cancer cell death, Cancer Lett, vol.354, pp.355-364, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01117384

L. Gao, G. S. Gülcüler, L. Golbach, H. Block, A. Zarbock et al., Endothelial cell-derived CD95 ligand serves as a chemokine in induction of neutrophil slow rolling and adhesion, vol.5, p.18542, 2016.